Upload Avatar (500 x 500)
Wei Wang
Mayo Clinic College of Medicine
University of Science and Technology of China
Anhui
Language: Chinese, English
Tumor Recurrence
Metastasis
Immune Microenvironment
Molecular Mechanisms
Bioinformatics
Clinical Research
Translational Research
Tumor Databases
Oncology
Cancer
Areas of Focus
- Molecular mechanisms of tumor recurrence, metastasis, and tumor immune microenvironment
- Application of bioinformatics analysis in clinical and basic tumor research
- Observational clinical research and clinical translational research in oncology
- Construction and scientific application of tumor clinical databases
Work Experience
- 2020/12–Present - The First Affiliated Hospital of USTC - Associate Chief Physician in Oncology
- 2015/12–2020/12 - The First Affiliated Hospital of USTC - Attending Physician in Oncology
- 2013/06–2015/12 - The First Affiliated Hospital of USTC - Resident Physician in Oncology
- 2009/07–2013/06 - The First Affiliated Hospital of USTC - Resident Physician in General Surgery
Academic Background & Achievements
- 2016/09–2018/06 PhD in Clinical Medicine (Oncology): Shandong University
- 2006/09–2009/06 Master's in Surgery (General Surgery): Anhui Medical University
- 2001/09–2006/06 Bachelor's in Clinical Medicine: Anhui Medical University
- Selected as a reserve candidate for the 13th batch of academic and technical leaders in Anhui Province
- First batch of 'Key Talents' by Anhui Provincial Health Commission
- Assistant leader of the 12th batch of Anhui Province 115 Industry Innovation Team
Publications
- Nanocodelivery of an NIR photothermal agent and an acid-responsive TLR7 agonist prodrug to enhance cancer photothermal immunotherapy and the abscopal effect., Chen B, Huang R, Zeng W, Wang W*, Min Y*., 2024
- Monophosphoryl lipid A-assembled nanovaccines enhance tumor immunotherapy., Li R, Hao Y, Pan W, Wang W*, Min Y*., 2023
- Tumor-associated mesenchymal stem cells promote hepatocellular carcinoma metastasis via a DNM3OS/KDM6B/TIAM1 axis., Wang W, Wang Q, Huang DB, Sun QK, Wu SS, Zhao YJ, Jia W, Hu DS, He YF., 2021
- Nanomedicine in lung cancer: Current states of overcoming drug resistance and improving cancer immunotherapy., Wang W, Hao Y, Liu Y, Li R, Huang DB, Pan YY., 2021
- The p53/miR-193a/EGFR feedback loop function as a driving force for non-small cell lung carcinoma tumorigenesis., Wang W, Shen XB, Huang DB, Yong Wang, Pan YY., 2019
- Peroxiredoxin 4 suppresses anoikis and augments growth and metastasis of hepatocellular carcinoma cells through the β-catenin/ID2 pathway., Wang W, Shen XB, Huang DB, Jia W, Liu WB, He YF., 2019
- 红细胞参数对胆道癌一线化疗疗效的预测作用:一项单中心回顾性研究., 王伟*,沈夏波,王刚,何义富,季楚舒,胡冰,潘跃银., 2019
Awards
- Science and Technology Progress Award (2021): First Prize by Anhui Provincial Government
- Top 100 '35 under 35' Most Promising Young Oncologists in China (2018): CSCO
- Outstanding Young Health Volunteer in Anhui Province
- Hospital-level 'Young Post Expert', 'Excellent Chief Resident', 'Excellent Doctor', 'Best Contribution - Individual Award', and 'Outstanding Young Technical Backbone'
